The Goldman Sachs technology M&A team, led by Sam Britton, has cashed in on its software focus and decades of experience to dominate 2019's biggest deals.Technologyread more
American small and medium-size companies that rely on China are scrambling to adjust their business plans in response to the escalating trade war.Traderead more
Here are the products that stand to be the most affected by China's new tariffs on $75 billion worth of U.S. goods.Marketsread more
The summit comes amid fears over a global economic slowdown, and U.S. tensions over trade allies, Iran and Russia.Politicsread more
The world's second biggest economy is past a point where it cannot ignore its enormous debt anymore, according to an analyst.China Economyread more
Carl Medlock used to work at Tesla. Now he's one of the few people in the U.S. that can fix the company's original Roadster electric vehicles.Technologyread more
Trump does have some powerful tools that would not require approval from U.S. Congress.Politicsread more
Stocks dropped after Donald Trump ordered that U.S. manufacturers find alternatives to their operations in China.US Marketsread more
As demand for lab monkeys continues to rise, U.S. scientists are reporting delays in research projects because they can't obtain enough animals, according to the National...Politicsread more
The European Union will respond in kind if the U.S. imposes tariffs on France over digital tax plan, EU chief Donald Tusk told G-7.Technologyread more
Trump said he will raise tariffs on $250 billion in Chinese goods to 30% and hike duties on another $300 billion in products to 15%.Politicsread more
Public health officials at a congressional hearing on Tuesday implored parents to vaccinate their children against the measles.
Despite the recently topic of measles vaccinations, its benefits far outweighed any conceivable costs, officials from U.S. health organizations told the House Energy and Commerce Committee's Subcommittee on Oversight and Investigations.
"There's no doubt if you do a risk benefit of the vaccine versus the disease, I think it's very, very clear that you have one of the most highly effective vaccines against any virus, and you have a highly contagious disease, measles, that can have serious complications," said Dr. Anthony Fauci, director of the National Institutes of Health's National Institute of Allergy and Infectious Diseases.
"So to me it's really a slam-dunk what the decision should be," Fauci said, reflecting on parents' vaccination considerations.
And while disease infections are far less prevalent now than 40 years ago, officials had declared the U.S. free of the virus at the beginning of the millennium. This year, there have already been more than 100 recorded cases, and officials attributed this resurgence to a lack of vaccinations.
"I think that parents' decisions to vaccinate their kids are related to their sense of the threat and their sense of the value of the intervention," said Dr. Anne Schuchat, who directs the Centers for Disease Control and Prevention's National Center for Immunization and Respiratory Diseases. "Many parents don't realize these diseases are still out there and if their children aren't vaccinated they'll come back."
Still, Schuchat said that a lack of sufficient public education may have contributed to the vaccinated children. "Most parents who weren't vaccinating didn't realize measles was still around and could be dangerous," she said.
This point needs to be emphasized, she explained, because the vaccine has public health and economic benefits for the country.
"Right now we know that the vaccines we're giving are saving lives and saving money—for each dollar we put in we get about $10 back for the childhood immunization series," she told the subcommittee.
Several of the congressional representatives at the hearing spoke up in favor of vaccinations, with Rep. Marsha Blackburn, R-Tenn., saying "this is far too serious an issue to be treated as a political football."
There is no federal mandate for vaccinations, the officials said, but states may require a certain level of protection to enter schools or childcare.
This policy contributed to the massive decline in measles cases beginning in the 1980s, Schuchat said.
The hearing included testimony from Dr.Kare Midthun—director of the Center for Biologics Evaluation and Research at the U.S. Food and Drug Administration—and Robin Robinson, who directs the Biomedical Advanced Research and Development Authority.
When asked by Republican Rep. Tim Murphy of Pennsylvania if they agreed with contemporary scientific literature that there is no proven connection between modern vaccinations and autism, all four witnesses said they did.